Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Trends in Microbiology|March 1, 1997
p53 and tumour viruses: catching the guardian off-guardJ C Neil, E R Cameron, E W BaxterJournal of Virology|September 18, 2001
Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic miceE W Baxter, K Blyth, E R Cameron, et al.Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Piperazinyl benzamidines: synthesis and affinity for the delta opioid receptorS O Nortey, E W Baxter, E E Codd, et al.Journal of Virology|April 1, 1996
Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?E W Baxter, K Blyth, L A Donehower, et al.Journal of Immunological Methods|February 9, 2020
Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNγ+LPS), M(IL-4) and M(IL-10) phenotypesE W Baxter, A E Graham, N A Re, et al.Oncogene|May 4, 1995
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 lossK Blyth, A Terry, M O'Hara, et al.Journal of Medicinal Chemistry|October 13, 1995
Piperazinylalkyl heterocycles as potential antipsychotic agentsM K Scott, E W Baxter, D J Bennett, et al.Journal of Medicinal Chemistry|October 13, 1995
N-aryl-N'-benzylpiperazines as potential antipsychotic agentsA B Reitz, E W Baxter, D J Bennett, et al.Journal of Medicinal Chemistry|June 17, 1998
Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptorsA B Reitz, E W Baxter, E E Codd, et al.Pageof 1